Director Slingsby Brian Taylor sold Mineralys Therapeutics ($MLYS) shares once on the open market in the last year, totaling $43.4 million, with the latest sale on November 20, 2025. His sales rank 368th among 11,678 insiders, above the average of $8.6 million per person and 6.4 transactions. He made no open market purchases.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 19, 2026 | Mineralys Therapeutics, Inc. | $MLYS | Slingsby Brian Taylor | Director | A | Stock Option | 8300 | $0.00 | 16,600.0000 | 79,139,956 | 100.00% | 0.01% |
| Feb. 19, 2026 | Mineralys Therapeutics, Inc. | $MLYS | Slingsby Brian Taylor | Director | J | Stock Option | 8300 | $0.00 | 8,300.0000 | 79,139,956 | 9999.99% | 0.01% |
| Feb. 19, 2026 | Mineralys Therapeutics, Inc. | $MLYS | Slingsby Brian Taylor | Director | J | Stock Option | 8300 | $0.00 | 8,300.0000 | 79,139,956 | 50.00% | 0.01% |
| Feb. 19, 2026 | Mineralys Therapeutics, Inc. | $MLYS | Slingsby Brian Taylor | Director | A | Common Stock | 6200 | $0.00 | 7,916,238.0000 | 79,139,956 | 0.08% | 0.01% |
| Feb. 19, 2026 | Mineralys Therapeutics, Inc. | $MLYS | Slingsby Brian Taylor | Director | J | Common Stock | 6200 | $0.00 | 7,910,038.0000 | 79,139,956 | 0.08% | 0.01% |
| Feb. 19, 2026 | Mineralys Therapeutics, Inc. | $MLYS | Slingsby Brian Taylor | Director | J | Common Stock | 6200 | $0.00 | 7,910,038.0000 | 79,139,956 | 0.08% | 0.01% |
| Nov. 20, 2025 | Mineralys Therapeutics, Inc. | $MLYS | Slingsby Brian Taylor | Director | S | Common Stock | 1000000 | $43.35 | 7,903,838.0000 | 79,139,956 | 11.23% | 1.26% |
| March 13, 2025 | Mineralys Therapeutics, Inc. | $MLYS | Slingsby Brian Taylor | Director | P | Common Stock | 259259 | $13.50 | 8,903,838.0000 | 49,835,637 | 3.00% | 0.52% |
| Feb. 13, 2025 | Mineralys Therapeutics, Inc. | $MLYS | Slingsby Brian Taylor | Director | A | Stock Option | 32900 | $0.00 | 65,800.0000 | 49,835,637 | 100.00% | 0.07% |
| Feb. 13, 2025 | Mineralys Therapeutics, Inc. | $MLYS | Slingsby Brian Taylor | Director | J | Stock Option | 32900 | $0.00 | 32,900.0000 | 49,835,637 | 50.00% | 0.07% |
| Feb. 13, 2025 | Mineralys Therapeutics, Inc. | $MLYS | Slingsby Brian Taylor | Director | J | Stock Option | 32900 | $0.00 | 32,900.0000 | 49,835,637 | 9999.99% | 0.07% |
| May 22, 2024 | Mineralys Therapeutics, Inc. | $MLYS | Slingsby Brian Taylor | Director | J | Stock Option | 22000 | $0.00 | 22,000.0000 | 0 | 50.00% | 0.00% |
| May 22, 2024 | Mineralys Therapeutics, Inc. | $MLYS | Slingsby Brian Taylor | Director | J | Stock Option | 22000 | $0.00 | 22,000.0000 | 0 | 9999.99% | 0.00% |
| July 24, 2024 | Mineralys Therapeutics, Inc. | $MLYS | Slingsby Brian Taylor | Director | S | Common Stock | 550000 | $13.05 | 8,644,579.0000 | 0 | 5.98% | 0.00% |
| May 22, 2024 | Mineralys Therapeutics, Inc. | $MLYS | Slingsby Brian Taylor | Director | A | Stock Option | 22000 | $0.00 | 22,000.0000 | 0 | 9999.99% | 0.00% |
| July 12, 2023 | Mineralys Therapeutics, Inc. | $MLYS | Slingsby Brian Taylor | Director | J | Stock Option | 88000 | $0.00 | 88,000.0000 | 0 | 9999.99% | 0.00% |
| July 12, 2023 | Mineralys Therapeutics, Inc. | $MLYS | Slingsby Brian Taylor | Director | J | Stock Option | 44000 | $0.00 | 88,000.0000 | 0 | 33.33% | 0.00% |
| Feb. 14, 2023 | Mineralys Therapeutics, Inc. | $MLYS | Slingsby Brian Taylor | Director | C | Series A Preferred Stock | 2171342 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 14, 2023 | Mineralys Therapeutics, Inc. | $MLYS | Slingsby Brian Taylor | Director | C | Common Stock | 4314093 | $0.00 | 8,944,579.0000 | 0 | 93.17% | 0.00% |
| Feb. 14, 2023 | Mineralys Therapeutics, Inc. | $MLYS | Slingsby Brian Taylor | Director | P | Common Stock | 250000 | $16.00 | 9,194,579.0000 | 0 | 2.79% | 0.00% |
| Feb. 14, 2023 | Mineralys Therapeutics, Inc. | $MLYS | Slingsby Brian Taylor | Director | C | Series B Preferred Stock | 2142751 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 9, 2023 | Mineralys Therapeutics, Inc. | $MLYS | Slingsby Brian Taylor | Director | A | Stock Option | 44000 | $0.00 | 44,000.0000 | 0 | 9999.99% | 0.00% |